CD72 downregulation on DN2 B cells associates with disease activity and resistance to rituximab in systemic lupus erythematosus

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Systemic Lupus Erythematosus

Genetic variability associates with ancestry, age at disease onset, organ involvement and disease severity in juvenile-onset systemic lupus erythematosus

Clin Immunol

Natoli V, Charras A, Hasoon MSR, Jorgensen AL, Smith EMD, Gutiérrez EC, Beresford MW, Hedrich CM, UK JSLE Cohort Study Group

doi: 10.1016/j.clim.2025.110540

Systemic Lupus Erythematosus

Objective and subjective sleep assessment in systemic lupus erythematosus and association with disease characteristics and quality of life

Rheumatology (Oxford)

Aggarwal A, Keret S, Handa R, Upadhyaya S, Gupta SJ

doi: 10.1093/rheumatology/keag092

Systemic Lupus Erythematosus

Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in Brazilian SLE patients

Rheumatology (Oxford)

Mata-Machado CM, Lanna CCD, Garrido JC, Monticielo OA, Klumb EM, Tres GL, Moura FM, Telles RW

doi: 10.1093/rheumatology/keaf366

Systemic Lupus Erythematosus

Upper limb function impairment is independently associated with all Lupus Quality of Life (LupusQoL) domains in systemic lupus erythematosus

Rheumatology (Oxford)

Arkoumanis I, Pappa M, Keramiotou K, Sfikakis PP, Tektonidou MG

doi: 10.1093/rheumatology/keag025

Autoimmune Disease

Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus

Ann Rheum Dis

Parodis I, Iacubino M, Rocco L, Nikolopoulos D, Palazzo L, Grimmett L, Kerr M, Bellocchi C, Vigone B, Santaniello A, Barturen G, Voskuyl AE, Alarcón-Riquelme ME, Beretta L

doi: 10.1016/j.ard.2025.12.005

Systemic Lupus Erythematosus

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

Ann Rheum Dis

Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber-Bouyer R, Hagen M, Bergmann C, Wirsching A, Bozec A, PRECISESADS Clinical Consortium, Schneider M, Barturen G, Bertsias G, Boumpas DT, Alarcón-Riquelme ME, Mackensen A, Schett G, Parodis I

doi: 10.1016/j.ard.2025.06.2132

Systemic Lupus Erythematosus

The Impact of Everyday Discrimination on Systemic Lupus Erythematous Disease Activity and Mental Health Outcomes

J Rheumatol

Benson KRK, Becerril A, Park J, Plantinga L, Yazdany J, Dall'Era M, Katz PP

doi: 10.3899/jrheum.2025-0631

Systemic Lupus Erythematosus

Physical activity in relation to the risk of systemic lupus erythematosus: A prospective study including 401,745 individuals

Rheumatology (Oxford)

Xu B, Ruan P, Wu H, Gao Y, Long H, Wu IXY, Lu Q

doi: 10.1093/rheumatology/keaf150

Related content

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Genetic variability associates with ancestry, age at disease onset, organ involvement and disease severity in juvenile-onset systemic lupus erythematosus

Objective and subjective sleep assessment in systemic lupus erythematosus and association with disease characteristics and quality of life

Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in Brazilian SLE patients

Upper limb function impairment is independently associated with all Lupus Quality of Life (LupusQoL) domains in systemic lupus erythematosus

Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus

The Impact of Everyday Discrimination on Systemic Lupus Erythematous Disease Activity and Mental Health Outcomes

Physical activity in relation to the risk of systemic lupus erythematosus: A prospective study including 401,745 individuals